Applied Lipid Technologies

Applied Lipid Technologies, Inc., a wholly owned subsidiary of Lobe Sciences Ltd., is a biopharmaceutical company specializing in the development of therapies for orphan and rare diseases, with a primary focus on sickle cell disease (SCD). The company's lead product, Altemia™, is a proprietary medical food consisting of a high-concentration polyunsaturated fatty acid triglyceride ester emulsion designed to reduce inflammation and improve outcomes for SCD patients. Utilizing its patented Natural Emulsion Technology (NET™), Applied Lipid Technologies provides a highly bioavailable oral formulation that delivers the equivalent of multiple standard fish oil capsules in a single dose. In addition to its commercial medical food, the company is advancing SAN100, a prescription drug candidate for the management of sickle cell disease.